|  Help  |  About  |  Contact Us

Publication : Fgf3-Fgf4-cis: A new mouse line for studying Fgf functions during mouse development.

First Author  Anderson MJ Year  2016
Journal  Genesis Volume  54
Issue  2 Pages  91-8
PubMed ID  26666435 Mgi Jnum  J:229949
Mgi Id  MGI:5754927 Doi  10.1002/dvg.22913
Citation  Anderson MJ, et al. (2016) Fgf3-Fgf4-cis: A new mouse line for studying Fgf functions during mouse development. Genesis 54(2):91-8
abstractText  The fibroblast growth factor (FGF) family consists of 22 ligands in mice and humans. FGF signaling is vital for embryogenesis and, when dysregulated, can cause disease. Loss-of-function genetic analysis in the mouse has been crucial for understanding FGF function. Such analysis has revealed that multiple Fgfs sometimes function redundantly. Exploring such redundancy between Fgf3 and Fgf4 is currently impossible because both genes are located on chromosome 7, about 18.5 kb apart, making the frequency of interallelic cross-over between existing mutant alleles too infrequent to be practicable. Therefore, we retargeted Fgf3 and Fgf4 in cis, generating an Fgf3 null allele and a conditional Fgf4 allele, subject to Cre inactivation. To increase the frequency of cis targeting, we used an F1 embryonic stem cell line that contained 129/SvJae (129) and C57BL/6J (B6) chromosomes and targeting constructs isogenic to the 129 chromosome. We confirmed cis targeting by assaying for B6/129 allele-specific single-nucleotide polymorphisms. We demonstrated the utility of the Fgf3(Delta) -Fgf4(flox) -cis mouse line by showing that the caudal axis extension defects found in the Fgf3 mutants worsen when Fgf4 is also inactivated. This Fgf3(Delta) -Fgf4(flox) -cis line will be useful to study redundancy of these genes in a variety of tissues and stages in development. genesis 54:91-98, 2016. Published 2016. This article is a US Government work and is in the public domain in the USA.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

15 Bio Entities

Trail: Publication

0 Expression